Full approval of Vitrakvi was based on results from three clinical trials in patients with unresectable or metastatic NTRK ...

The FDA has fully approved larotrectinib for adult and pediatric patients with solid tumors that harbor an NTRK gene fusion.

The U.S. Food and Drug Administration (FDA) has granted full approval to Vitrakvi (larotrectinib) for the treatment of adult ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...

Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted full approval for VITRAKVI® (larotrectinib), a first-in-class TRK inhibitor for the treatment of adult and pediatric ...

Rash was also a significant predictor of dengue among both ... Additionally, in adults, muscle pain, thrombocytopenia, neutropenia and high aspartate transaminase were significant univariate ...

Drug rashes can be an unwanted side effect of many medications. Learn which medications can cause these skin reactions.

There are many other types of rashes with a wide variety of causes. Treatment for a rash requires the correct diagnosis and can include medication and avoiding potential triggers.  Easily ...

Neutropenia, according to the Mayo Clinic, is a disease that occurs when "the body has too few neutrophils, a type of white blood cells." This is important because "all white blood cells help the ...